1181 related articles for article (PubMed ID: 30968371)
41. Visceral Adiposity Index (VAI) in Children and Adolescents with Obesity: No Association with Daily Energy Intake but Promising Tool to Identify Metabolic Syndrome (MetS).
Vizzuso S; Del Torto A; Dilillo D; Calcaterra V; Di Profio E; Leone A; Gilardini L; Bertoli S; Battezzati A; Zuccotti GV; Verduci E
Nutrients; 2021 Jan; 13(2):. PubMed ID: 33525454
[TBL] [Abstract][Full Text] [Related]
42. Waist-to-height ratio is better than body mass index and waist circumference as a screening criterion for metabolic syndrome in Han Chinese adults.
Yang H; Xin Z; Feng JP; Yang JK
Medicine (Baltimore); 2017 Sep; 96(39):e8192. PubMed ID: 28953680
[TBL] [Abstract][Full Text] [Related]
43. Performance of anthropometric indicators as predictors of metabolic syndrome in Brazilian adolescents.
Oliveira RG; Guedes DP
BMC Pediatr; 2018 Feb; 18(1):33. PubMed ID: 29415673
[TBL] [Abstract][Full Text] [Related]
44. Body Adiposity Index and Body Roundness Index in Identifying Insulin Resistance Among Adults Without Diabetes.
Feng J; He S; Chen X
Am J Med Sci; 2019 Feb; 357(2):116-123. PubMed ID: 30665492
[TBL] [Abstract][Full Text] [Related]
45. Gender Differences in the Relationships among Metabolic Syndrome and Various Obesity-Related Indices with Nonalcoholic Fatty Liver Disease in a Taiwanese Population.
Lin IT; Lee MY; Wang CW; Wu DW; Chen SC
Int J Environ Res Public Health; 2021 Jan; 18(3):. PubMed ID: 33498329
[TBL] [Abstract][Full Text] [Related]
46. Predictive ability of obesity- and lipid-related indicators for metabolic syndrome in relatively healthy Chinese adults.
Duan Y; Zhang W; Li Z; Niu Y; Chen Y; Liu X; Dong Z; Zheng Y; Chen X; Feng Z; Wang Y; Zhao D; Liu Q; Li H; Peng H; Sun X; Cai G; Jiang H; Chen X
Front Endocrinol (Lausanne); 2022; 13():1016581. PubMed ID: 36465613
[TBL] [Abstract][Full Text] [Related]
47. Body roundness index is a superior indicator to associate with the cardio-metabolic risk: evidence from a cross-sectional study with 17,000 Eastern-China adults.
Xu J; Zhang L; Wu Q; Zhou Y; Jin Z; Li Z; Zhu Y
BMC Cardiovasc Disord; 2021 Feb; 21(1):97. PubMed ID: 33593274
[TBL] [Abstract][Full Text] [Related]
48. The feasibility of two anthropometric indices to identify metabolic syndrome, insulin resistance and inflammatory factors in obese and overweight adults.
Li G; Wu HK; Wu XW; Cao Z; Tu YC; Ma Y; Li BN; Peng QY; Cheng J; Wu B; Zhou Z
Nutrition; 2019 Jan; 57():194-201. PubMed ID: 30176572
[TBL] [Abstract][Full Text] [Related]
49. Validation of Surrogate Anthropometric Indices in Older Adults: What Is the Best Indicator of High Cardiometabolic Risk Factor Clustering?
Ramírez-Vélez R; Pérez-Sousa MÁ; Izquierdo M; Cano-Gutierrez CA; González-Jiménez E; Schmidt-RioValle J; González-Ruíz K; Correa-Rodríguez M
Nutrients; 2019 Jul; 11(8):. PubMed ID: 31344803
[TBL] [Abstract][Full Text] [Related]
50. Predicting metabolic syndrome by visceral adiposity index, body roundness index, dysfunctional adiposity index, lipid accumulation product index, and body shape index in adults.
Bilgin Göçer D; Baş M; Çakır Biçer N; Hajhamidiasl L
Nutr Hosp; 2022 Aug; 39(4):794-802. PubMed ID: 35815743
[TBL] [Abstract][Full Text] [Related]
51. Association of adiposity indices with cardiometabolic multimorbidity among 101,973 chinese adults: a cross-sectional study.
Qin X; Chen C; Wang J; Cai A; Feng X; Jiang X; Feng Y
BMC Cardiovasc Disord; 2023 Oct; 23(1):514. PubMed ID: 37865773
[TBL] [Abstract][Full Text] [Related]
52. Anthropometric Cutoffs for Increased Cardiometabolic Risk Among Lebanese Adults: A Cross-Sectional Study.
Nasreddine L; Bachir N; Kharroubi S; Chamieh MC; Mehio Sibai A; Hwalla N; Naja F
Metab Syndr Relat Disord; 2019 Dec; 17(10):486-493. PubMed ID: 31566527
[No Abstract] [Full Text] [Related]
53. Comparative analysis of anthropometric indices of obesity as correlates and potential predictors of risk for hypertension and prehypertension in a population in Nigeria.
Ononamadu CJ; Ezekwesili CN; Onyeukwu OF; Umeoguaju UF; Ezeigwe OC; Ihegboro GO
Cardiovasc J Afr; 2017 Mar/Apr 23; 28(2):92-99. PubMed ID: 27701484
[TBL] [Abstract][Full Text] [Related]
54. Comparison of Anthropometric and Atherogenic Indices as Screening Tools of Metabolic Syndrome in the Kazakh Adult Population in Xinjiang.
Zhang XH; Zhang M; He J; Yan YZ; Ma JL; Wang K; Ma RL; Guo H; Mu LT; Ding YS; Zhang JY; Liu JM; Li SG; Niu Q; Rui DS; Guo SX
Int J Environ Res Public Health; 2016 Apr; 13(4):428. PubMed ID: 27092520
[TBL] [Abstract][Full Text] [Related]
55. Comparison of the predictive power of adiposity indices and blood lipid indices for diagnosis of prediabetes.
Zhang Y; Wang M; Zuo Y; Su X; Wen J; Zhai Q; He Y
Hormones (Athens); 2022 Dec; 21(4):683-690. PubMed ID: 36166170
[TBL] [Abstract][Full Text] [Related]
56. Assessing metabolic syndrome prediction quality using seven anthropometric indices among Jordanian adults: a cross-sectional study.
Al-Shami I; Alkhalidy H; Alnaser K; Mukattash TL; Al Hourani H; Alzboun T; Orabi A; Liu D
Sci Rep; 2022 Dec; 12(1):21043. PubMed ID: 36473903
[TBL] [Abstract][Full Text] [Related]
57. Obesity-related indices are associated with albuminuria and advanced kidney disease in type 2 diabetes mellitus.
Ou YL; Lee MY; Lin IT; Wen WL; Hsu WH; Chen SC
Ren Fail; 2021 Dec; 43(1):1250-1258. PubMed ID: 34461808
[TBL] [Abstract][Full Text] [Related]
58. Optimal Obesity- and Lipid-Related Indices for Predicting Metabolic Syndrome in Chronic Kidney Disease Patients with and without Type 2 Diabetes Mellitus in China.
Li H; Wang Q; Ke J; Lin W; Luo Y; Yao J; Zhang W; Zhang L; Duan S; Dong Z; Chen X
Nutrients; 2022 Mar; 14(7):. PubMed ID: 35405947
[TBL] [Abstract][Full Text] [Related]
59. Capacity adiposity indices to identify metabolic syndrome in subjects with intermediate cardiovascular risk (MARK study).
Gomez-Marcos MA; Gomez-Sanchez L; Patino-Alonso MC; Recio-Rodriguez JI; Gomez-Sanchez M; Rigo F; Marti R; Agudo-Conde C; Maderuelo-Fernandez JA; Ramos R; Garcia-Ortiz L; Rodriguez-Sanchez E
PLoS One; 2019; 14(1):e0209992. PubMed ID: 30682054
[TBL] [Abstract][Full Text] [Related]
60. The lipid accumulation product is a powerful tool to diagnose metabolic dysfunction-associated fatty liver disease in the United States adults.
Li H; Zhang Y; Luo H; Lin R
Front Endocrinol (Lausanne); 2022; 13():977625. PubMed ID: 36407325
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
